1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Acne Medication Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Acne Medication Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Acne Medication Market Regional Analysis
6.2 Europe Acne Medication Market Revenue 2020-2030 (US$ Million)
6.3 Europe Acne Medication Market Forecast Analysis
7. Europe Acne Medication Market Analysis – by Therapeutic Class
7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Acne Medication Market Analysis – by Formulation
8.1 Topical Medication and Oral Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication and Oral Medication: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Acne Medication Market Analysis – by Acne Type
9.1 Non-Inflammatory Acne and Inflammatory Acne
- 9.1.1 Overview
- 9.1.2 Non-Inflammatory Acne and Inflammatory Acne: Europe Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Acne Medication Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Acne Medication Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 Europe Acne Medication Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 UK: Europe Acne Medication Market Breakdown, by Therapeutic Class
- 10.2.1.1.2 UK: Europe Acne Medication Market Breakdown, by Formulation
- 10.2.1.1.3 UK: Europe Acne Medication Market Breakdown, by Acne Type
- 10.2.1.2 Germany:
Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Germany: Europe Acne Medication Market Breakdown, by Therapeutic Class
- 10.2.1.2.2 Germany: Europe Acne Medication Market Breakdown, by Formulation
- 10.2.1.2.3 Germany: Europe Acne Medication Market Breakdown, by Acne Type
- 10.2.1.3 France:
Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 France: Europe Acne Medication Market Breakdown, by Therapeutic Class
- 10.2.1.3.2 France: Europe Acne Medication Market Breakdown, by Formulation
- 10.2.1.3.3 France: Europe Acne Medication Market Breakdown, by Acne Type
- 10.2.1.4 Russia:
Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Russia: Europe Acne Medication Market Breakdown, by Therapeutic Class
- 10.2.1.4.2 Russia: Europe Acne Medication Market Breakdown, by Formulation
- 10.2.1.4.3 Russia: Europe Acne Medication Market Breakdown, by Acne Type
- 10.2.1.5 Italy:
Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Italy: Europe Acne Medication Market Breakdown, by Therapeutic Class
- 10.2.1.5.2 Italy: Europe Acne Medication Market Breakdown, by Formulation
- 10.2.1.5.3 Italy: Europe Acne Medication Market Breakdown, by Acne Type
- 10.2.1.6 Rest of Europe:
Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Acne Medication Market Breakdown, by Therapeutic Class
- 10.2.1.6.2 Rest of Europe: Europe Acne Medication Market Breakdown, by Formulation
- 10.2.1.6.3 Rest of Europe: Europe Acne Medication Market Breakdown, by Acne Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Teva Pharmaceutical Industries Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Almirall SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Johnson & Johnson
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bausch Health Companies Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Galderma SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Pfizer Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 GSK Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Viatris Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Pierre Fabre SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations